Inlet Private Wealth, LLC Gilead Sciences, Inc. Transaction History

Inlet Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $194,093 - $214,245	-3,105 Closed	0 $0
Q2 2019 Jul 22, 2019	SELL	$61.87 - $69.38 $234,796 - $263,297	-3,795 Reduced 55.0%	3,105 $206,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $93,795 - $105,075	1,500 Added 27.78%	6,900 $449,000
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $326,916 - $426,600	5,400 New	5,400 $338,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Inlet Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Inlet Private Wealth, LLC with notifications on news.